INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. NVDA
4. PSKY
5. TSLA
6. AMD
7. USO
8. META
9. AMC
10. MSFT

Go back to INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings
(NASDAQ: INMB) Delayed: 2.33 --0 (-0%)
Previous Close $2.33    52 Week High $ 
Open $2.35    52 Week Low $ 
Day High $2.42    P/E N/A 
Day Low $2.29    EPS $ 
Volume 231,506       

(NASDAQ: INMB) Delayed: 2.33 --0 (-0%)
Previous Close $2.33    52 Week High $ 
Open $2.35    52 Week Low $ 
Day High $2.42    P/E N/A 
Day Low $2.29    EPS $ 
Volume 231,506